Suchergebnisse - "Henry, Brandon M"

PubPharm (10)

1

Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Lippi, G. | Henry, B. | Plebani, M.

2

Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine : a proof-of-concept study

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Salvagno, G. | Pighi, L. | Henry, B. | +3

3

Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Salvagno, G. | Pighi, L. | Henry, B. | +7

4

Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +3

CommentOn: Clin Chem Lab Med. 2022 Apr 27;60(7):1110-1115. - PMID 35473824

5

Serum C reactive protein predicts humoral response after BNT162b2 booster administration

enthalten in: The Journal of infection | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +2

6

Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Lippi, G. | Henry, B. | Montagnana, M. | +1

CommentOn: Clin Chem Lab Med. 2022 Feb 16;60(5):771-777. - PMID 35170269

7

Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +3

8

Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay : a pooled analysis

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Lippi, G. | Henry, B. | Adeli, K.

9

The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +3

10

The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Salvagno, G. | Henry, B. | Lippi, G.

1
[1]